Lipanthyl Penta/Lipanthyl Supra Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

The most commonly reported ADRs during LIPANTHYL PENTA 145/LIPANTHYL SUPRA 160 therapy are digestive, gastric or intestinal disorders.
The following undesirable effects have been observed during placebo-controlled clinical trials (n=2344) with the indicated frequencies as follows: (See table.)

Click on icon to see table/diagram/image

In addition to those events reported during clinical trials, the following side effects have been reported spontaneously during postmarketing use of LIPANTHYL PENTA 145/LIPANTHYL SUPRA 160. A precise frequency cannot be estimated from the available data and is therefore classified as "not known".
Respiratory, thoracic and mediastinal disorders: Interstitial lung disease.
Musculoskeletal, connective tissue and bone disorders: Rhabdomyolysis.
Hepatobiliary disorders: jaundice, complications of cholelithiasis (e.g. cholecystitis, cholangitis, biliary colic).
Skin and Subcutaneous Tissue Disorders: severe cutaneous reactions (e.g. erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).
Nervous system disorders: Fatigue.

View ADR Monitoring Form

Lipanthyl Penta/Lipanthyl Supra Adverse Reactions

fenofibrate

Manufacturer:

Abbott

Distributor:

Zuellig Pharma